Primary experimental recordPositive observation

PMC9654460::ACT054308

PS14

Evidence text

Paper-level observation

PS14 challenge showed a dose-dependent inhibition at 5 µM (19.71 ± 1%) followed by the other higher concentration and the results are significantly different from the control (p < 0.05).

textConfidence: medium

Assay observation

Activity

Immunomodulatory

Subtype

Anti-inflammatory

Measure

percent_inhibition

Comparator

Raw observation

19.71 ± 1%

Normalized measurement

=19.71%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

lipoxygenase

Assay method

Not reported by source

Sequence

PTECQVGTTCKVES

Standardization

ready simple

Source publication

Anti-Cancer and Anti-Inflammatory Activities of a Short Molecule, PS14 Derived from the Virulent Cellulose Binding Domain of Aphanomyces invadans, on Human Laryngeal Epithelial Cells and an In Vivo Zebrafish Embryo Model

Molecules · 2022

DOI 10.3390/molecules27217333 PMC9654460

Parent mention

Related peptide identities

PEPDIA-PLP-002255

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.